Holistic Bioprocess Development Across Scales Using Multi-Fidelity Batch Bayesian Optimization
Abstract
Bioprocesses are central to modern biotechnology, enabling sustainable production in pharmaceuticals, specialty chemicals, cosmetics, and food. However, developing high-performing processes is costly and complex, requiring iterative, multi-scale experimentation from microtiter plates to pilot reactors. Conventional Design of Experiments (DoE) approaches often struggle to address process scale-up and the joint optimization of reaction conditions and biocatalyst selection. We propose a multi-fidelity batch Bayesian optimization framework to accelerate bioprocess development and reduce experimental costs. The method integrates Gaussian Processes tailored for multi-fidelity modeling and mixed-variable optimization, guiding experiment selection across scales and biocatalysts. A custom simulation of a Chinese Hamster Ovary bioprocess, capturing non-linear and coupled scale-up dynamics, is used for benchmarking against multiple simulated industrial DoE baselines. Multiple case studies show how the proposed workflow can achieve a reduction in experimental costs and increased yield. This work provides a data-efficient strategy for bioprocess optimization and highlights future opportunities in transfer learning and uncertainty-aware design for sustainable biotechnology.
Cite
@article{arxiv.2508.10970,
title = {Holistic Bioprocess Development Across Scales Using Multi-Fidelity Batch Bayesian Optimization},
author = {Adrian Martens and Mathias Neufang and Alessandro Butté and Moritz von Stosch and Antonio del Rio Chanona and Laura Marie Helleckes},
journal= {arXiv preprint arXiv:2508.10970},
year = {2025}
}
Comments
25 pages, 12 figures